Now showing items 81-100 of 144
G-CSF Treatment of Healthy Pediatric Donors Affects Their Hematopoietic Microenvironment Through Changes in Bone Marrow Plasma Cytokines and Stromal Cells
Although G-CSF mobilized peripheral blood stem cell (PBSC) transplantation is commonly used in adults, bone marrow (BM) is still the preferred stem cell source in pediatric stem cell transplantation. Despite the fact that ...
Long Term Follow-Up of the Patients with Severe Combined Immunodeficiency After Hematopoietic Stem Cell Transplantation: A Single-Center Study
Background: We aimed to evaluate hematopoietic stem cell transplantation (HSCT) related outcomes of patients with severe combined immunodeficiency (SCID). Methods: We retrospectively collected data from SCID patients ...
SLE'de hematolojik bulgular
deri ve lenf nodu muayenesi
Genomic Spectrum and Phenotypic Heterogeneity of Human IL-21 Receptor Deficiency
Biallelic inactivating mutations in IL21R causes a combined immunodeficiency that is often complicated by cryptosporidium infections. While eight IL-21R-deficient patients have been reported previously, the natural course, ...
Pre-conditioning Serum Uric Acid as a Risk Factor for Sinusoidal Obstruction Syndrome of the Liver in Children Undergoing Hematopoietic Stem Cell Transplantation
Uric acid, a known danger signal released from injured cells, is one of the valuable signs of inflammation. We aimed to evaluate the association of serum uric acid level before the start of conditioning regimen with the ...
Evaluation of Drug-Drug İnteractions and Their Clinical İmportance in a Pediatric Hematopoietic Stem Cell Transplantation Unit
Background and Aims: Many drugs with narrow therapeutic range and high toxicity risk are used in hematopoietic stem cell transplantation (HSCT) Units. The increase in the number of drugs raises the likelihood of interactions. ...
Long-Term Skin Findings İn Patients With Fanconi Anemia After Allogeneic Hematopoietic Stem Cell Transplantation
Long-term skin findings in patients with Fanconi anemia after allogeneic hematopoietic stem cell transplantation